Walgreens Boots Alliance (NASDAQ:WBA) Releases Earnings Results, Beats Estimates By $0.30 EPS

Walgreens Boots Alliance (NASDAQ:WBA) released its quarterly earnings data on Tuesday. The pharmacy operator reported $1.40 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.10 by $0.30, MarketWatch Earnings reports. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The business had revenue of $32.78 billion during the quarter, compared to analyst estimates of $36.16 billion. During the same quarter last year, the business earned $1.52 earnings per share. Walgreens Boots Alliance’s quarterly revenue was down 8.5% compared to the same quarter last year.

Shares of Walgreens Boots Alliance stock traded up $0.16 on Thursday, hitting $55.06. 398,320 shares of the company traded hands, compared to its average volume of 6,665,064. The company has a current ratio of 0.67, a quick ratio of 0.32 and a debt-to-equity ratio of 0.58. The company has a market cap of $47.57 billion, a PE ratio of 109.44, a PEG ratio of 1.52 and a beta of 0.44. The stock’s 50 day moving average price is $50.41 and its 200-day moving average price is $43.08. Walgreens Boots Alliance has a 52 week low of $33.36 and a 52 week high of $56.78.

The business also recently announced a quarterly dividend, which was paid on Friday, March 12th. Stockholders of record on Friday, February 19th were given a dividend of $0.4675 per share. This represents a $1.87 dividend on an annualized basis and a dividend yield of 3.40%. The ex-dividend date of this dividend was Thursday, February 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 39.45%.

A number of research analysts recently commented on WBA shares. TheStreet downgraded shares of Walgreens Boots Alliance from a “b-” rating to a “c” rating in a report on Thursday, January 7th. Robert W. Baird raised Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and raised their price objective for the company from $41.00 to $55.00 in a research note on Monday, January 11th. Cowen boosted their target price on Walgreens Boots Alliance from $41.00 to $53.00 and gave the company a “market perform” rating in a research report on Monday. Truist increased their price target on Walgreens Boots Alliance from $44.00 to $48.00 in a report on Friday, January 8th. Finally, Truist Financial lifted their price objective on shares of Walgreens Boots Alliance from $40.00 to $44.00 in a research note on Tuesday, January 5th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $46.22.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

See Also: Why do earnings reports matter?

Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.